UK Study Finds Autoimmune Disorders Affect Around One in Ten People
According to a recent UK population-based study published in The Lancet, approximately one in ten individuals are now affected by
Read moreAccording to a recent UK population-based study published in The Lancet, approximately one in ten individuals are now affected by
Read moreChiesi Global Rare Diseases and Protalix BioTherapeutics, Inc. have received marketing authorization from the European Commission (EC) for their drug,
Read moreStemBioSys, Inc. (StemBioSys) announced on Monday, the launch of NeuroMatrix™, an astrocyte-derived extracellular matrix that is developed to enable the
Read moreThe novel 3DProSeed ® StromaLine ® developed by Ectica is an advantageous collection of pre-developed and well characterized stromal models
Read moreA new Oxford-GSK Institute of Molecular and Computational Medicine will be established through a substantial five-year cooperation between GlaxoSmithKline plc
Read moreNew Phase 3 Data has shown a positive correlation between the human monoclonal antibody ADUHELM™ treatment effect on biomarkers and
Read moreGenentech’s investigational antibody for the treatment of early-stage Alzheimer’s disease, Gantenerumab, has been granted Breakthrough Therapy Designation by the U.S.
Read moreThe unique 3DProSeed® ready-to-use 96-well microtiter plate developed by Ectica Technologies contains pre-assembled synthetic hydrogels, ready for screening 3D cell
Read moreThe cutting-edge multispectral tissue cytometry hardware TissueFAXS SPECTRA, developed by TissueGnostics, has the unique ability to enable multispectral imaging of
Read moreThe modern brightfield and fluorescence scanning system by TissueGnostics offers unparalleled flexibility for researchers working on tissue-based cell culture analysis
Read more